Speaker illustration

Ms Naja Emborg Vinding

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Stroke severity and subsequent mortality are worse with atrial fibrillation than in patients without atrial fibrillation

Event: ESC CONGRESS 2019

Topic: Stroke in Atrial Fibrillation

Session: Identifying and managing complications of atrial fibrillation

Thumbnail

Shifting from vitamin K antagonist to dabigatran in atrial fibrillation: differences according to dose

Event: ESC CONGRESS 2017

Topic: Antiarrhythmic drugs

Session: Drug treatment

Thumbnail

This platform is supported by

logo Novo Nordisk